CCN2 and Fabry disease: Other profibrotic markers, including connective tissue growth factor (CTGF), lysyl oxidase (LOX), and TGF-β, are also attenuated by finerenone [151], further reinforcing its potential to mitigate fibrotic remodeling in FD.